Marlborough, Massachusetts-based Boston Scientific Corporation (BSX) is a global medical technology company that develops, manufactures, and markets minimally invasive medical devices. With a market capitalization of approximately $68.5 billion, the company provides innovative solutions across cardiovascular, electrophysiology, endoscopy, urology, neuromodulation, and other medical specialties, serving healthcare providers and patients in more than 120 countries.
Shares of this medtech giant have significantly underperformed the broader market over the past year. BSX has declined 56.8% during this period, while the broader S&P 500 Index ($SPX) has rallied nearly 14.8%. Likewise, the stock is down 51.7% year-to-date, trailing the index's 6.9% gain over the same period.